|
Aug 28
|
Bolt Biotherapeutics to Participate in Upcoming September Conferences
|
|
Dec 21
|
Pacira Appoints Frank D. Lee as Chief Executive Officer
|
|
Dec 5
|
Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®
|
|
Nov 9
|
Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
|
|
Nov 7
|
Bolt Biotherapeutics to Present at Stifel 2023 Healthcare Conference
|
|
Aug 9
|
Bolt Biotherapeutics Second Quarter 2023 Earnings: Misses Expectations
|
|
Aug 7
|
Bolt Biotherapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
|